| Jeanne Bignell, | |
|
35020 Alaskan View Lane, Soldotna, AK 99669 | |
| (907) 491-1280 | |
| Not Available |
| Full Name | Jeanne Bignell |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 35020 Alaskan View Lane, Soldotna, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689048282 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | NURP7205 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeanne Bignell, 35020 Alaskan View Lane, Soldotna, AK 99669 Ph: (907) 491-1280 | Jeanne Bignell, 35020 Alaskan View Lane, Soldotna, AK 99669 Ph: (907) 491-1280 |
News Archive
Reduced striatal dopamine transporter availability is already present in patients with Parkinson's disease who go on to develop impulse control disorders, a study shows.
Even as herculean efforts are being made to extend the reach of vaccination against COVID-19 to all the regions of the world, there is a dire need for rapid and sensitive tests to assess the antibody response to the various vaccines used and to monitor antibody titers over time. A new preprint describes a new approach to this problem which could be applied to other molecules of interest as well, both in laboratories and at the point of care.
The National High Magnetic Field Laboratory at Florida State University is planning to build a state-of-the-art magnet system that will transform the study of complex environmental and biological samples. A better understanding of fossil and biological fuels, for example, could lead to applications for reducing carbon emissions and the development of new, sustainable fuels.
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration has accepted for review the Supplemental New Drug Application for ZORVOLEX (diclofenac), a lower dose nonsteroidal anti-inflammatory drug, for the proposed indication of treatment of osteoarthritis pain in adults. ZORVOLEX was approved by FDA in October 2013 for the treatment of mild to moderate acute pain in adults.
One-step screening for both genetic and chromosomal abnormalities has come a stage closer as scientists announced that an embryo test they have been developing has successfully screened cells taken from spare embryos that were known to have cystic fibrosis.
› Verified 6 days ago
Scott Mitchell, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 106 Robin Pl, Soldotna, AK 99669 Phone: 907-283-5172 Fax: 907-262-8787 | |
Jeffery Everett Rood, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 354 Tyee St, Soldotna, AK 99669 Phone: 907-714-4521 | |
Stacey Lee Sutherlin, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 354 Tyee St, Soldotna, AK 99669 Phone: 907-714-5870 | |
Mrs. Sarah Peck, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 37456 Arctic Tern Road, Soldotna, AK 99669 Phone: 907-395-7024 | |
Terry Arleen Kidd, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 245 N Binkley St Ste 202, Soldotna, AK 99669 Phone: 907-714-4521 |